$NAKA

Bailey David F purchased $180K of NAKA (indirect holdings)

Bailey David F (Chief Executive Officer) purchased 32,134 indirectly-held shares of Nakamoto Inc. (NAKA) at $5.59 ($0.18M total) on 2026-08-19.

Original reporting
SEC EDGAR · Bailey David F
Published Aug 21, 2026, 10:21 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 21, 2026, 10:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$NAKA
Neutral
medium confidence
Mentioned
$NAKA
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NAKANeutralLow
01

Why it matters

The purchase is modest and unlikely to move the stock significantly on its own.

02

Market read

Small insider purchase with limited immediate trading relevance.

03

What to watch

Potential future dilution or secondary offerings could offset the effect of this purchase.

Relevance 5/10Novelty 4/10Timing: filing date 2026-08-21

Background

Form 4 filings disclose insider trades; investors watch for signals of confidence.

Company-level read

Ticker impact

$NAKANeutralMedium confidence
Context

CEO Bailey David F bought 32,134 shares for $179,580 in an open-market purchase disclosed on Form 4.

Expected impact

Minor upward pressure if market perceives insider buying positively.

Evidence & confidence

The transaction amount is under $200k and represents a small ownership stake; impact is limited.

Market effects

No immediate sector impact; reflects typical insider activity in small-cap tech.

Limited to U.S. micro-cap investors.

Minimal

Counterpoint

Insider buying could be a signal of upcoming positive news, but size suggests limited conviction.

Key entities

  • Bailey David F

    Chief Executive Officer of Nakamoto Inc.

  • Nakamoto Inc.

    Issuer of the NAKA ticker.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NAKAMed

Nakamoto Inc. (NAKA): Results of Operations and Financial Condition

Nakamoto Inc. (NAKA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Nakamoto Reports Second Quarter 2026 Financial and Operating Results First Full Quarter as an Integrated Bitcoin Company Highlights Early Execution, Product Innovation, and Growing Institutional Engagement NASHVILLE, Tenn. – August 13, 2026: Nakamoto Inc. (NASDAQ: NA

$MSTRMed

Bitcoin treasury companies unwind holdings as the DAT model comes under pressure

Bitcoin treasury companies are selling bitcoin and restructuring as share prices fall and debt obligations rise. Strategy (MSTR) has sold about 3,620 BTC and authorized more. Satsuma (SATS) approved liquidation of 668 BTC. Smarter Web (SWC) sold 178 BTC, Sequans (SQNS) sold 1,025 BTC, and Nakamoto (NAKA) sold about 284 BTC. Miners MARA and Bitdeer also reduced holdings, citing AI pivots.

$NAKAMedAI 8/10

Nakamoto Fuels 20% Surge for NAKA Stock With Latest Bitcoin Sale

Nakamoto Inc. (NAKA) said it sold about 600 BTC and related derivative positions for net proceeds of about $48 million to repay $45 million of its Kraken loan. It extended most remaining debt to June 2027 and authorized a $25 million share repurchase. Nakamoto retains about 4,467 BTC; stock rose ~20%. The company expects ~$4 million lower annual financing costs.

$NAKAHighAI 9/10

A Bitcoin Treasury Company Has a Doctor on Staff, But Why?

Nakamoto Inc. (NAKA) defended its Chief Medical Officer role, saying it stems from its 2025 reverse merger with KindlyMD, a Utah pain-management company, and that maintaining the healthcare business is tied to Nasdaq listing requirements. Analysts cited NAKA’s Q1 2026 10-Q showing a $238 million net loss and $2.3 million operating revenue, plus $7.3 million insider compensation, amid 58% dilution and a 1-for-40 reverse split.